Ganirelix - NDC Database

9 records found
Page:1
0052-0301 Jul 29, 1999
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Organon USA Inc.
0548-5001 Jun 20, 2022
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection by Amphastar Pharmaceuticals, Inc.
55566-1000 Jan 01, 2019
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Ferring Pharmaceuticals Inc.
55566-1010 Feb 28, 2022
Fyremadel 250 ug/.5ml Subcutaneous Injection, Solution by Ferring Pharmaceuticals Inc.
65219-028 Mar 24, 2023
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection by Fresenius Kabi USA, LLC
68083-472 Feb 28, 2023
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Gland Pharma Limited
70748-274 Feb 14, 2024
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Lupin Pharmaceuticals, Inc.
71288-554 Jun 06, 2022
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Meitheal Pharmaceuticals Inc.
78206-138 Jun 01, 2021
Ganirelix Acetate 250 ug/.5ml Subcutaneous Injection, Solution by Organon LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.